- Home
- PASG vs ZJYL Comparison
PASG vs ZJYL Comparison
Compare PASG & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PASG | ZJYL |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6M | 32.7M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | PASG | ZJYL |
|---|---|---|
| Price | $15.11 | $0.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $34.50 | N/A |
| AVG Volume (30 Days) | 85.2K | ★ 284.5K |
| Earning Date | 03-03-2026 | 08-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $22,826,624.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.41 |
| Revenue Growth | N/A | ★ 13.42 |
| 52 Week Low | $5.12 | $0.16 |
| 52 Week High | $20.00 | $1.12 |
Technical Indicators
Market Signals| Indicator | PASG | ZJYL |
|---|---|---|
| Relative Strength Index (RSI) | 54.61 | N/A |
| Support Level | $13.33 | N/A |
| Resistance Level | $20.00 | N/A |
| Average True Range (ATR) | 2.12 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 47.32 | 0.00 |
Price Performance
Historical ComparisonAbout PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.